<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; overall</title>
	<atom:link href="http://www.tapanray.in/tag/overall/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Will mandatory disclosure of ‘payments to physicians’ by the pharmaceutical companies be an overall part of “Healthcare reform process” in the US and what about India?</title>
		<link>http://www.tapanray.in/will-mandatory-disclosure-of-payments-to-physicians-by-the-pharmaceutical-companies-be-an-overall-part-of-healthcare-reform-process-in-the-us-and-what-about-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=will-mandatory-disclosure-of-payments-to-physicians-by-the-pharmaceutical-companies-be-an-overall-part-of-healthcare-reform-process-in-the-us-and-what-about-india</link>
		<comments>http://www.tapanray.in/will-mandatory-disclosure-of-payments-to-physicians-by-the-pharmaceutical-companies-be-an-overall-part-of-healthcare-reform-process-in-the-us-and-what-about-india/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 01:00:21 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[about]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[disclosure]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[mandatory]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[overall]]></category>
		<category><![CDATA[part]]></category>
		<category><![CDATA[payments]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[what]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=727</guid>
		<description><![CDATA[The brief Scenario in India: In India over 20, 000 pharmaceutical companies of varying size and scale of operations are currently operating. It is alleged that lack of regulatory scrutiny is prompting many of these companies to adapt to ‘free-for-all’ &#8230; <a href="http://www.tapanray.in/will-mandatory-disclosure-of-payments-to-physicians-by-the-pharmaceutical-companies-be-an-overall-part-of-healthcare-reform-process-in-the-us-and-what-about-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/will-mandatory-disclosure-of-payments-to-physicians-by-the-pharmaceutical-companies-be-an-overall-part-of-healthcare-reform-process-in-the-us-and-what-about-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
